AwardTape · Defense awards · Research and development · Health R&D · HT942523C0078
HT942523C0078: -$0 definitive contract to Hexamer Therapeutics Inc
Hexamer Therapeutics Inc holds a definitive contract from Defense Health Agency with -$0 obligated since Oct 2023 and $3.9M obligated over its life, against a ceiling of $3.9M. Latest action Jun 3, 2026.
Research and development services ba230121 titled self assembling vaccine platform
| PIID | HT942523C0078 |
|---|---|
| Type | definitive contract |
| Company | Hexamer Therapeutics Inc |
| Agency | Defense Health Agency |
| Contracting office | DEFENSE HEALTH AGENCY |
| Category | Research and development · Health R&D |
| PSC | AN11 HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| NAICS | 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| Obligated since Oct 2023 | -$0 |
| Total obligated (lifetime) | $3.9M |
| Ceiling (base and all options) | $3.9M |
| Base date | Sep 29, 2023 |
| Latest action | Jun 3, 2026 |
| End date | Mar 31, 2027 |
| Actions since Oct 2023 | 5 |
| Pricing | Firm fixed price |
| Competition | Full and open competition |
| Place of performance | WA |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial